☆ 4.7 Article

Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection

VACCINES (2023)

Related references

Note: Only part of the references are listed.

Article Virology

SARS-CoV-2 Detection and Culture in Different Biological Specimens from Immunocompetent and Immunosuppressed COVID-19 Patients Infected with Two Different Viral Strains

Maria Cassia Mendes-Correa et al.

Summary: By analyzing samples from 98 immunocompetent and 25 immunosuppressed individuals over five weeks, it was found that SARS-CoV-2 detection was highest in nasopharyngeal swabs and the duration of viral shedding varied among different clinical specimens and individuals. Prolonged shedding of potentially infectious virus primarily occurred in immunosuppressed individuals and virus replication was observed in a minority of subjects in vitro.

VIRUSES-BASEL (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Delivery of superoxide dismutase by TAT and abalone peptides for the protection of skin cells against oxidative stress

Gustavo Roncoli Reigado et al.

Summary: The study focused on fusing Trichoderma reesei superoxide dismutase with transactivator of transcription (TAT) of HIV-1 and abalone (Ab) peptides to enhance antioxidant protection on skin cells. The results revealed that the recombinant Ab-TrSOD was more effective in reducing oxidative stress compared to TrSOD without cell-penetrating peptide, and showed no cytotoxic effects on cells at the concentrations tested.

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2

Sam Afkhami et al.

Summary: The study found that using adenoviral vectors with a multivalent vaccine through intranasal immunization can generate better mucosal immune responses, including local and systemic antibody responses, mucosal tissue-resident memory T cells, and mucosal trained innate immunity, and provide protection against multiple viral variants.

CELL (2022)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

Peter J. Halfmann et al.

Summary: The recent study by the SAVE/NIAID network shows that the B.1.1.529 Omicron variant causes milder lung disease in rodents, which is consistent with preliminary human clinical data.

NATURE (2022)

Add to Collection

Article Immunology

Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein

Anirban Sengupta et al.

Summary: This study investigated the effectiveness of using a combination of specific antigens and adjuvants through intranasal administration in inducing immune responses. The results showed that this strategy was able to induce both mucosal and systemic immune responses. Additionally, lipid adjuvants were found to enhance the vaccine effect.

VACCINES (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

From a recombinant key antigen to an accurate, affordable serological test: Lessons learnt from COVID-19 for future pandemics

Renata G. F. Alvim et al.

Summary: This study discusses the development of an accurate and affordable COVID-19 antibody test, including the production of a recombinant protein antigen and the validation of an enzyme-linked immunosorbent assay (ELISA). The test showed high accuracy with 98.6% specificity and 95% sensitivity, and dried blood spots collected on test strips could replace conventional plasma/serum samples. The estimated cost was low, and the entire process could be completed in four months. This research is important for reliable and affordable seroepidemiological surveillance during pandemics.

BIOCHEMICAL ENGINEERING JOURNAL (2022)

Add to Collection

Article Virology

Neutralizing antibodies to SARS-CoV-2 variants of concern including Delta and Omicron in subjects receiving mRNA-1273, BNT162b2, and Ad26.COV2.S vaccines

George Fei Zhang et al.

Summary: SARS-CoV-2 vaccines show varying levels of effectiveness against different variants, with Omicron being the most challenging due to its high number of mutations. Two-dose mRNA-1273 and BNT162b2 vaccines provide robust neutralizing antibodies against multiple variants, but their effectiveness wanes after 6 months. One dose of Ad26.COV2.S vaccine induces weaker antibodies, particularly against Omicron. Booster shots with mRNA-based vaccines are recommended 5 months after full immunization, and mRNA-based vaccines are suggested 2 months after Ad26.COV2.S vaccination.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein

Julia T. Castro et al.

Summary: This study generated a chimeric protein (SpiN) that can elicit specific T cell responses and provide strong protection against SARS-CoV-2 infection. The results suggest that vaccine formulations that induce effector T cells specific for the nucleocapsid antigen and receptor binding domain of SARS-CoV-2 can improve COVID-19 vaccines and potentially overcome immune escape by variants of concern.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Immunology

Intradermal Immunization of SARS-CoV-2 Original Strain Trimeric Spike Protein Associated to CpG and AddaS03 Adjuvants, but Not MPL, Provide Strong Humoral and Cellular Response in Mice

Luan Firmino-Cruz et al.

Summary: The study found that formulations containing AddaS03, CpG, or a combination of both as adjuvants could induce strong immune responses, generate high levels of neutralizing antibodies, and activate CD4(+) T cells. These findings are significant for the development of COVID-19 vaccines.

VACCINES (2022)

Add to Collection

Article Immunology

Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens

Zijun Wang et al.

Summary: The study compares antibody immune responses following different COVID-19 vaccination regimens, revealing significant differences that can inform improved vaccination strategies. The findings highlight the importance of vaccine selection in antibody production and protection.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Add to Collection

Article Virology

Dynamics of SARS-CoV-2 Variants of Concern in Vaccination Model City in the State of Sao Paulo, Brazil

Svetoslav Nanev Slavov et al.

Summary: Brazil, with one of the highest rates of COVID-19 infections and deaths, has implemented a successful vaccination program that reduced mortality and morbidity. The study conducted in the town of Serrana revealed that the vaccine campaign significantly reduced deaths and morbidity during the Gamma and Delta variants of concern (VOC). However, the Omicron VOC showed rapid substitution and morbidity rates despite vaccination.

VIRUSES-BASEL (2022)

Add to Collection

Article Medicine, General & Internal

Absence of neutralizing antibodies against the Omicron SARS-CoV-2 variant in convalescent sera from individuals infected with the ancestral SARS-CoV-2 virus or its Gamma variant

Lucy Santos Villas-Boas et al.

Summary: This study demonstrates that neutralizing antibodies generated by infection with the SARS-CoV-2 ancestral strain or the Gamma variant are not effective against the Omicron variant.

CLINICS (2022)

Add to Collection

Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Immunology

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

Mohamad-Gabriel Alameh et al.

Summary: Lipid nanoparticle (LNP)-encapsulated nucleoside-modified mRNA vaccines have intrinsic adjuvant activity that enhances durable and protective antibody responses. Compared to the widely used MF59-like adjuvant AddaVax, this LNP formulation outperforms and relies on specific components and cytokine induction for its adjuvant activity.

IMMUNITY (2021)

Add to Collection

Article Hematology

Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing

Alfredo Mendrone-Junior et al.

Summary: This study suggests that SARS-CoV-2 IgG immunoassays (S/CO) can predict high anti-SARS-CoV-2 nAbs titers. Different criteria for identifying donors with >= 1:160 nAbs titers have been proposed in this study, all showing high efficacy.

TRANSFUSION (2021)

Add to Collection

Review Immunology

Production and Function of Immunoglobulin A

Timothy W. Hand et al.

Summary: IgA is unique among antibodies as it can survive on mucosal surfaces and play a critical role in preventing enteric infections, although its ability to activate effector functions is limited. Its distinct antigen-binding repertoire is shaped by local cues and the microbiota, crucial for regulating intestinal bacteria.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)

Add to Collection

Article Medicine, General & Internal

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Einav G. Levin et al.

Summary: A study in Israel revealed that waning immunity after receiving two doses of the BNT162b2 vaccine led to an increase in the incidence of SARS-CoV-2 infection. Levels of spike-binding IgG and neutralizing antibodies decreased more significantly in men, individuals aged 65 or older, and immunosuppressed individuals in a longitudinal study involving nearly 4000 healthcare workers.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Editorial Material Multidisciplinary Sciences

ARPA-H: Accelerating biomedical breakthroughs

Francis S. Collins et al.

SCIENCE (2021)

Add to Collection

Article Cell Biology

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice

Ahmed O. Hassan et al.

Summary: Intranasal immunization with ChAd-SARS-CoV-2-S in mice induces durable neutralizing and Fc effector antibody responses, providing protection against historical and emerging SARS-CoV-2 strains.

CELL REPORTS (2021)

Add to Collection

Article Immunology

Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2

Benjamin Israelow et al.

Summary: Research demonstrates that both humoral and cellular immunity play a role in clearing SARS-CoV-2, and convalescent mice or mice vaccinated with mRNA are protected from infection with both the wild type virus and the B.1.351 variant. This protection is mainly mediated by antibody response rather than cellular immunity.

SCIENCE IMMUNOLOGY (2021)

Add to Collection

Article Medical Laboratory Technology

Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia

Daniel K. W. Chu et al.

CLINICAL CHEMISTRY (2020)

Add to Collection

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Add to Collection

Article Immunology

Allergen-Specific Immunotherapy With Liposome Containing CpG-ODN in Murine Model of Asthma Relies on MyD88 Signaling in Dendritic Cells

Ricardo Wesley Alberca-Custodio et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Linlin Bao et al.

NATURE (2020)

Add to Collection

Article Hematology

Screening forSARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program

Silvano Wendel et al.

TRANSFUSION (2020)

Add to Collection

Article Virology

The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies

Elahe Seyed Hosseini et al.

VIROLOGY (2020)

Add to Collection

Article Virology

Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies

Elif Nurtop et al.

VIROLOGY JOURNAL (2018)

Add to Collection

Review Immunology

Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems

Prosper N. Boyaka

JOURNAL OF IMMUNOLOGY (2017)

Add to Collection

Article Immunology

CpG-ODN Shapes Alum Adjuvant Activity Signaling via MyD88 and IL-10

Luciana Cristina Mirotti et al.

FRONTIERS IN IMMUNOLOGY (2017)

Add to Collection

Article Immunology

The Sensing of Environmental Stimuli by Follicular Dendritic Cells Promotes Immunoglobulin A Generation in the Gut

Keiichiro Suzuki et al.

IMMUNITY (2010)

Add to Collection

Review Immunology

Mucosal Immunity: Induction, Dissemination, and Effector Functions

P. Brandtzaeg

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)

Add to Collection

Article Virology

Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus

Paul B. McCray et al.

JOURNAL OF VIROLOGY (2007)

Add to Collection

Article Biotechnology & Applied Microbiology

Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus

RH See et al.

JOURNAL OF GENERAL VIROLOGY (2006)

Add to Collection

Article Immunology

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities

J Vollmer et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2004)

Add to Collection

Article Immunology

Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-α induction in plasmacytoid dendritic cells

G Hartmann et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.